TOMOX compared to FOLFOX4 as first-line treatment in patients (pts) with advanced colorectal cancer (ACRC): Preliminary results of a multicenter randomized phase II trial

3599

  • Grávalos, C.
  • García-Girón, C.
  • León, A. I.
  • Salud, A.
  • Esteban, B.
  • Sevilla, I.
  • Maurel, J.
  • Murias, A.
  • García-Rico, E.
  • Cortés-Funes, H. G.
Onkologie 27:p 26, August 2004.
Copyright © 2004 S. Karger AG, Basel
View full text|Download PDF